Catalyst Wire Dossier Catalyst Wire Dossier

Vemurafenib (Zelboraf)

vemurafenib · Roche
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Vemurafenib (Zelboraf), covering 2015-04-30 to 2018-05-09. Get the full timeline:

Most recent: Clinical Trial Update: ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma [Phase 2]

See pricing